Pan-Cancer Pharmacogenetics: Targeted Sequencing Panels vs Exome Sequencing

Pan-Cancer Pharmacogenetics: Targeted Sequencing Panels vs Exome Sequencing

Explore the advantages of IDT's xGen Exome Panel for pan-cancer pharmacogenetics studies in this informative 14-minute webinar. Delve into various types of sequencing, methods for collecting pharmacogenetic cancer data, and the importance of variant-drug interactions. Gain insights into the pan-cancer atlas and understand why exome sequencing may be preferable to smaller targeted panel solutions for comprehensive genetic analysis in cancer research. Discover how this approach can enhance the study of pharmacogenetics across multiple cancer types and potentially improve personalized treatment strategies.